Research & Development
European Commission approves Bristol Myers Squibb's Sotyktu for psoriatic arthritis
8 May 2026 - Biopharmaceutical company Bristol Myers Squibb (NYSE:BMY) announced on Friday that the European Commission has approved Sotyktu (deucravacitinib), alone or with methotrexate, for adults w...
Rznomics receives FDA RMAT designation for HCC candidate RZ‑001
...
BioArctic and Eisai report FDA extension of Leqembi Iqlik review
8 May 2026 - Swedish research-based biopharma company BioArctic AB (STO:BIOA-B) and its Japanese partner Eisai Co Ltd (TYO:4523) announced on Friday that the US Food and Drug Administration (FDA) has ...
Mezzion reveals pre-IND FDA feedback on udenafil development in ADPKD
8 May 2026 - South Korean biopharmaceutical company Mezzion Pharma Co Ltd on Thursday announced written feedback from the US Food and Drug Administration (FDA) following a pre-IND Type C Guidance meet...
Altasciences and Certara form strategic partnership to accelerate early drug development
7 May 2026 - Drug development solution company Altasciences announced on Thursday that it has entered into a strategic partnership with biosimulation software specialist Certara Inc (NASDAQ:CERT) to a...
Partner Therapeutics' BIZENGRI receives FDA Commissioner's National Priority Voucher for NRG1 fusion-positive cholangiocarcinoma
7 May 2026 - Biotechnology company Partner Therapeutics Inc (PTx) announced on Wednesday that the US Food and Drug Administration (FDA) has awarded a Commissioner's National Priority Voucher (CNP...